Shimizu T, Oba T, Oshi M, Ito KI, et al. Eribulin promotes proliferation of CD8(+) T cells and potentiates T cell-mediated anti-tumor activity against triple-negative breast cancer cells. Breast Cancer Res Treat 2023 Sep 21. doi: 10.1007/s10549-023-07111.
PMID: 37733186